Israeli Prime Minister Benjamin Netanyahu, 76, disclosed on Friday that he had been diagnosed with prostate cancer and completed treatment. The cancer was detected early, with a malignant tumor less than a centimeter in size and no evidence of metastasis. Netanyahu underwent targeted radiation therapy, which he said eliminated the cancer completely. He delayed the release of his annual medical report by two months to prevent Iran from using the diagnosis as propaganda amid the ongoing war. The prime minister’s office confirmed that Netanyahu is in excellent health and has resumed his duties without complications.
Core Facts and Developments
Netanyahu underwent surgery for an enlarged prostate in December 2024, during which a small malignant tumor was discovered. Subsequent tests confirmed the cancer was localized, and he began radiation therapy about two and a half months ago. The treatment was completed recently, and medical reports indicate no remaining signs of cancer. Netanyahu stated that he chose to delay the public disclosure to avoid giving Iran an opportunity to exploit the news for propaganda purposes.
Context and Background
The prime minister’s office released an official medical report confirming the diagnosis and treatment. Netanyahu shared the news on social media, thanking the medical team at Hadassah Medical Centre in Jerusalem. He emphasized that the cancer was detected early and treated successfully, with no long-term health concerns. The delay in disclosure was strategic, as Netanyahu sought to avoid any potential propaganda advantage for Iran during the conflict.
Political and Strategic Implications
Netanyahu’s decision to withhold the diagnosis reflects broader concerns about the war with Iran and the potential for adversaries to use personal health information against Israel. The prime minister’s office has not disclosed the exact timeline of the diagnosis or treatment, but sources indicate the cancer was detected several months ago. The revelation comes amid ongoing tensions in the region, with Israel’s leadership under scrutiny for its handling of both domestic and international challenges.